Medirom Healthcare Technologies Inc (MRM)
Official siteCONSUMER CYCLICAL • PERSONAL SERVICES • NASDAQ
Market Cap: $2.19M
Last updated: Nov 17, 2026 at 10:26 AM ET
Medirom Healthcare Technologies Inc (MRM) Financials: Revenue, Profit and Cash Flow
Medirom Healthcare Technologies reported revenue of JPY 4.04M for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was JPY 374.72K with a net margin of 9.3%. The quarter ended Mar 31, 2026 had revenue of JPY 611.99M and net income of JPY 63.43M.
Revenue and Margins
The operating margin was 10.3% in the fiscal year ended Dec 2025, the highest of the 8 years shown. Over the 7 years to Dec 2025, revenue fell from JPY 3.43B, a compound annual decline of 61.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 4.04M | -100.0% | 96.6% | 10.3% | 9.3% |
| Dec 2024 | 8.30B | +21.5% | 27.1% | -0.2% | 1.8% |
| Dec 2023 | 6.83B | -1.8% | 23.0% | -5.7% | 1.7% |
| Dec 2022 | 6.95B | +28.5% | 27.4% | 1.4% | 2.1% |
| Dec 2021 | 5.41B | +61.9% | 26.2% | -7.0% | -18.3% |
| Dec 2020 | 3.34B | -14.5% | 12.8% | -22.3% | -16.1% |
| Dec 2019 | 3.91B | +13.8% | 24.3% | 0.9% | 0.4% |
| Dec 2018 | 3.43B | N/A | 27.9% | 2.1% | 1.9% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 99.7% from the year before. In the quarter ended Mar 2026, net income fell 91.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.04M | 8.30B | 6.83B | 6.95B | 5.41B | 3.34B | 3.91B | 3.43B |
| Cost of revenue | 137.79K | 6.05B | 5.26B | 5.05B | 3.99B | 2.91B | 2.96B | 2.48B |
| Gross profit | 3.90M | 2.25B | 1.57B | 1.90B | 1.42B | 428.95M | 950.76M | 956.87M |
| Research and development | 0 | 0 | 0 | 0 | 0 | 13.47M | 0 | 0 |
| Operating income | 414.31K | -18.10M | -391.58M | 96.97M | -379.53M | -746.09M | 34.35M | 73.27M |
| Net income | 374.72K | 148.76M | 115.05M | 148.97M | -990.73M | -539.17M | 17.34M | 66.31M |
| EBITDA | 513.79K | 387.50M | 310.08M | 373.63M | -228.07M | -551.16M | 125.07M | 158.31M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 611.99M | 611.99M | 3.15B | 3.15B | 4.82B | 4.82B | 3.48B | 3.48B | 3.59B | 3.59B | 3.24B | 3.24B |
| Gross profit | 609.86M | 609.86M | 341.53M | 341.53M | 1.67B | 1.67B | 576.56M | 576.56M | 889.91M | 889.91M | 678.96M | 678.96M |
| Operating income | 70.63M | 70.63M | -814.63M | -814.63M | 618.57M | 618.57M | -636.67M | -636.67M | -81.32M | -81.32M | -310.26M | -310.26M |
| Net income | 63.43M | 63.43M | -671.06M | -671.06M | 730.94M | 730.94M | -582.18M | -582.18M | 470.47M | 470.47M | -355.07M | -355.07M |
Balance Sheet
As of Dec 2025, short-term debt of JPY 1.74B exceeded cash and equivalents by 1.72B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 4.16B | 8.09B | 6.85B | 6.75B | 5.75B | 5.71B | 4.76B | 4.52B |
| Current assets | 3.57B | 2.71B | 1.76B | 2.36B | 1.38B | 2.09B | 1.38B | 934.04M |
| Cash and equivalents | 20.14M | 329.40M | 106.35M | 605.45M | 370.62M | 1.44B | 513.62M | 211.69M |
| Total liabilities | 2.82B | 6.90B | 6.63B | 6.81B | 5.96B | 5.22B | 4.16B | 4.64B |
| Short-term debt | 1.74B | 1.91B | 1.26B | 868.94M | 917.47M | 900.60M | 1.08B | 1.18B |
| Long-term debt | N/A | 764.20M | 1.05B | 1.15B | 746.59M | 668.38M | 150.53M | 342.77M |
| Shareholder equity | 1.33B | 933.27M | 210.88M | -59.38M | -208.34M | 491.26M | 600.06M | -117.56M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.16B | 4.16B | 7.98B | 7.98B | 8.09B | 8.09B | 5.83B | 5.83B | 6.85B | 6.85B | 6.06B | 6.06B |
| Total liabilities | 2.82B | 2.82B | 7.49B | 7.49B | 6.90B | 6.90B | 6.19B | 6.19B | 6.63B | 6.63B | 6.47B | 6.47B |
| Cash and equivalents | 20.14M | 20.14M | 32.62M | 32.62M | 329.40M | 329.40M | 144.65M | 144.65M | 106.35M | 106.35M | 117.73M | 117.73M |
| Shareholder equity | 1.33B | 1.33B | 442.34M | 442.34M | 933.27M | 933.27M | -363.20M | -363.20M | 210.88M | 210.88M | -414.44M | -414.44M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2024.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.33B | -631.74M | -685.70M | -557.23M | -366.42M | 7.87M | 141.87M |
| Capital expenditures | 564.81M | 135.84M | 120.74M | 113.78M | 73.56M | 7.41M | 34.30M |
| Free cash flow | -1.90B | -767.58M | -806.44M | -671.01M | -439.98M | 464.00K | 107.57M |
| Investing cash flow | 361.39M | -328.58M | 580.44M | -83.94M | -139.60M | -37.93M | -79.39M |
| Financing cash flow | 1.19B | 461.21M | 340.10M | -427.95M | 1.43B | 331.99M | -74.47M |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -342.02M | -342.02M | -545.96M | -545.96M | -831.32M | -785.72M | 27.79M | -21.70M | -610.04M | -610.04M | -335.14M | N/A |
| Capital expenditures | 16.02M | 16.02M | 546.12M | 546.12M | 18.70M | 18.70M | 79.60M | 79.60M | 56.24M | 56.24M | 80.37M | 0 |
| Free cash flow | -358.04M | -358.04M | -1.09B | -1.09B | -850.01M | -804.41M | -51.81M | -101.30M | -666.28M | -666.28M | -415.52M | N/A |
Frequently Asked Questions About MRM
What is Medirom Healthcare Technologies' annual revenue?
Medirom Healthcare Technologies reported revenue of JPY 4.04M for the fiscal year ended Dec 31, 2025.
How fast is Medirom Healthcare Technologies' revenue growing?
Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -91.7%.
Is Medirom Healthcare Technologies profitable?
Yes. Medirom Healthcare Technologies reported net income of JPY 374.72K for the fiscal year ended Dec 31, 2025, with a net margin of 9.3%.
How much debt does Medirom Healthcare Technologies have?
The balance sheet dated Dec 31, 2025 reported short-term debt of JPY 1.74B and cash and equivalents of JPY 20.14M.
What is MRM's profit margin?
For the fiscal year ended Dec 31, 2025, Medirom Healthcare Technologies reported gross margin of 96.6%, operating margin of 10.3% and net margin of 9.3%.
MRM pages: Overview, Financials